Protocol Ledger

NCT04539275 · Phase III · TERMINATED

VA CoronavirUs Research and Efficacy Studies-1

Interventional Phase III clinical trial protocol NCT04539275 sponsored by VA Office of Research and Development in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-11-16 Enrollment: 75 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04539275
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)75 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04539275
Protocol FieldVerified Registry Value
NCT IdentifierNCT04539275
Consolidated Lead SponsorVA Office of Research and Development
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusTERMINATED
Registered Enrollment75 participants (ACTUAL)
Registered Start Date2020-11-16
WhyStopped ClassificationInsufficient / Slow Accrual

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI